Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04438083
Title A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors CRISPR Therapeutics AG
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | CAN | AUS

Facility Status City State Zip Country Details
Research Site 2 Duarte California 91010 United States Details
Research Site 5 Hartford Connecticut 06520 United States Details
Research Site 4 Houston Texas 77030 United States Details
Research Site 3 Salt Lake City Utah 84112 United States Details
Research Site 1 Melbourne Victoria 3000 Australia Details
Research Site 6 Toronto Ontario M5G 2M9 Canada Details
Research Site 7 Amsterdam North Holland 1066 Netherlands Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field